# Opportunity #1: Alpha-1 Symptom Checker & Risk Assessment Tool

**Project**: Alpha1Life.com Enhancement
**Owner**: Mark Egly Foundation
**Created**: November 11, 2025
**Priority**: Must-Have (Phase 2-3)
**Estimated Cost**: $5,000 - $10,000
**Timeline**: 2-3 months development

---

## 🎯 Executive Summary

**The Problem**: An estimated 90% of people with Alpha-1 Antitrypsin Deficiency (AATD) are undiagnosed. Many suffer for years with misdiagnosed asthma, COPD, or liver disease before getting the correct diagnosis.

**The Solution**: An interactive "Should I Get Tested for Alpha-1?" tool that assesses risk based on symptoms, family history, and risk factors, then provides personalized recommendations.

**The Impact**:

- Help 1,000+ people discover they should get tested (Year 1)
- Reduce time to diagnosis by providing clear guidance
- Drive traffic to Alpha1Life.com (high SEO value)
- Generate leads for genetic testing services (partnership revenue potential)

**The Investment**: $5K-$10K one-time development + $500/year maintenance

---

## 📊 Market Opportunity

### The Undiagnosed Crisis

**Statistics**:

- ~100,000 Americans have AATD (estimated)
- Only 10,000-15,000 are diagnosed
- **85,000-90,000 people don't know they have it**
- Average time to diagnosis: 7.2 years from first symptoms
- Average number of doctors seen before correct diagnosis: 3-5

**Why People Don't Get Diagnosed**:

1. Rare disease - most doctors have never seen a case
2. Symptoms mimic common conditions (asthma, COPD, bronchitis)
3. Simple blood test exists but doctors don't think to order it
4. Lack of awareness (both public and medical community)

**The Opportunity**:

- If our tool helps just 100 people get diagnosed in Year 1, we could change 100 lives
- Each diagnosis prevents years of improper treatment
- Early diagnosis = better outcomes (treatment works best when started early)

---

## 🛠️ Tool Features & Functionality

### Core Assessment

**Step 1: Symptom Screening** (Multiple choice)

```
┌────────────────────────────────────────────┐
│  SHOULD I GET TESTED FOR ALPHA-1?          │
│                                            │
│  Answer a few quick questions to find out  │
│  if Alpha-1 testing might be right for you.│
│                                            │
│  This takes about 3 minutes.               │
│                                            │
│  ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━  │
│                                            │
│  QUESTION 1 OF 12                          │
│                                            │
│  Do you have any of these lung symptoms?   │
│  (Check all that apply)                    │
│                                            │
│  [ ] Shortness of breath                   │
│  [ ] Wheezing                              │
│  [ ] Chronic cough                         │
│  [ ] Frequent respiratory infections       │
│  [ ] Diagnosed with asthma or COPD         │
│  [ ] None of the above                     │
│                                            │
│  [NEXT →]                                  │
└────────────────────────────────────────────┘
```

**Question Categories**:

1. **Lung Symptoms** (5 questions)
   - Shortness of breath (SOB)
   - Wheezing
   - Chronic cough
   - Respiratory infections
   - Existing diagnoses (asthma, COPD, emphysema)

2. **Liver Symptoms** (3 questions)
   - Unexplained liver disease
   - Elevated liver enzymes
   - Cirrhosis
   - Jaundice

3. **Family History** (2 questions)
   - Family members with AATD
   - Family members with early COPD or liver disease

4. **Risk Factors** (2 questions)
   - Age (AATD usually appears 30-50 years old)
   - Smoking history (accelerates lung damage)

5. **Other Indicators** (2 questions)
   - Panniculitis (rare skin condition associated with AATD)
   - Young age at COPD diagnosis (<45)
   - COPD with no smoking history

---

### Risk Scoring Algorithm

**Point System** (Behind the scenes):

**High-Risk Indicators** (10 points each):

- Diagnosed with COPD before age 45
- Family member with confirmed AATD
- Emphysema with no/minimal smoking history
- Unexplained liver cirrhosis
- Panniculitis (rare skin condition)

**Moderate-Risk Indicators** (5 points each):

- Chronic respiratory symptoms
- COPD diagnosis (any age)
- Asthma that doesn't respond well to treatment
- Elevated liver enzymes (no other cause)
- Family history of early lung disease

**Low-Risk Indicators** (2 points each):

- Occasional wheezing
- Smoker or ex-smoker
- Over age 50 with no symptoms

**Score Interpretation**:

- **0-5 points**: Low risk - Testing not typically recommended
- **6-15 points**: Moderate risk - Consider testing, especially if symptoms persist
- **16-25 points**: High risk - Testing strongly recommended
- **26+ points**: Very high risk - Testing highly recommended, see specialist

---

### Results Page

**Low Risk Result**:

```
┌────────────────────────────────────────────┐
│  YOUR RESULTS                              │
│                                            │
│  LOW RISK FOR ALPHA-1                      │
│                                            │
│  Based on your answers, Alpha-1 testing    │
│  is not typically recommended at this time.│
│                                            │
│  ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━  │
│                                            │
│  WHAT THIS MEANS:                          │
│  You don't have the common signs that      │
│  suggest Alpha-1. However, if you develop  │
│  new symptoms or have concerns, talk to    │
│  your doctor.                              │
│                                            │
│  ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━  │
│                                            │
│  NEXT STEPS:                               │
│  • Monitor your health                     │
│  • If you develop lung or liver symptoms,  │
│    retake this assessment                  │
│  • Talk to your doctor if concerned        │
│                                            │
│  [LEARN MORE ABOUT ALPHA-1]                │
│  [RETAKE ASSESSMENT]                       │
│  [TALK TO OUR COMMUNITY]                   │
└────────────────────────────────────────────┘
```

---

**High Risk Result**:

```
┌────────────────────────────────────────────┐
│  YOUR RESULTS                              │
│                                            │
│  HIGH RISK FOR ALPHA-1                     │
│  Testing is strongly recommended           │
│                                            │
│  Based on your answers, you have several   │
│  indicators that suggest Alpha-1 testing   │
│  would be appropriate.                     │
│                                            │
│  ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━  │
│                                            │
│  WHY TESTING MATTERS:                      │
│  • Alpha-1 is often misdiagnosed as asthma │
│    or COPD                                 │
│  • Simple blood test can confirm diagnosis │
│  • Early diagnosis = better outcomes       │
│  • Treatment is available and effective    │
│  • Family members may also need testing    │
│                                            │
│  ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━  │
│                                            │
│  NEXT STEPS:                               │
│  1. Talk to your doctor about Alpha-1      │
│     testing                                │
│  2. Request a "serum AAT level" blood test │
│  3. If low, request genetic testing        │
│     (PI phenotype or genotype)             │
│                                            │
│  [DOWNLOAD: "Questions to Ask Your Doctor"]│
│  [FIND AN ALPHA-1 SPECIALIST]              │
│  [FIND TESTING LOCATIONS]                  │
│  [EMAIL ME THESE RESULTS]                  │
│                                            │
│  ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━  │
│                                            │
│  NOT SURE WHAT TO SAY TO YOUR DOCTOR?      │
│  We can help!                              │
│  [DOWNLOAD DOCTOR DISCUSSION GUIDE]        │
└────────────────────────────────────────────┘
```

---

### Additional Features

**1. Personalized Resources**

- Results page includes resources tailored to risk level
- Low risk: General education about AATD
- Moderate risk: "What to watch for" symptom guide
- High risk: Specialist finder, testing locations, doctor discussion guide

**2. Email Results**

- Option to email results to self (for doctor visit)
- Includes summary, next steps, resources
- Opt-in to MEF newsletter

**3. Print/PDF Results**

- Printable results page
- Bring to doctor appointment

**4. Follow-Up**

- For high-risk users who provide email:
  - 1 week: "Did you talk to your doctor?"
  - 1 month: "Have you been tested?"
  - 3 months: "We're here to help" (with resources)

**5. Share Results** (Optional, sensitive)

- "My doctor doesn't believe me" - share with family for support
- Social share (anonymized): "I just learned I should get tested for Alpha-1"

---

## 🎨 User Experience Design

### User Flow

```
Landing Page
    ↓
"Should I Get Tested?" CTA
    ↓
Intro Screen (what to expect, time estimate)
    ↓
Question 1 (Lung Symptoms)
    ↓
Question 2 (Liver Symptoms)
    ↓
Question 3 (Family History)
    ↓
... (12 questions total)
    ↓
Calculating... (animated, 2-3 seconds)
    ↓
Results Page (Low/Moderate/High/Very High Risk)
    ↓
Next Steps + Resources
    ↓
Optional: Email Results
    ↓
Optional: Download Doctor Guide
    ↓
Optional: Find Specialist
    ↓
Optional: Join Community
```

### Progress Indicators

```
Question 3 of 12  [████████░░░░░░░░░░░░] 25%
```

### Mobile-First Design

- Large tap targets
- One question per screen (mobile)
- Save progress (if user navigates away)
- Quick load times (<1 second per question)

---

## 🔒 Medical & Legal Compliance

### Medical Disclaimers

**Required on every page**:

> **Important Medical Disclaimer**: This tool is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Only a healthcare provider can diagnose Alpha-1 Antitrypsin Deficiency through proper testing. If you have health concerns, please consult your doctor.

**On results page**:

> **This is NOT a diagnosis**: This assessment cannot diagnose Alpha-1. Only genetic testing ordered by your doctor can confirm Alpha-1 Antitrypsin Deficiency. These results are based on typical symptoms and risk factors, but every person is different.

### Privacy & Data

**Data Collection**:

- Answers are NOT stored (unless user opts in)
- If user provides email, store only for follow-up (with consent)
- No sharing of individual results
- Aggregate data (anonymized) may be used for research

**HIPAA Considerations**:

- Tool is screening/educational, not diagnostic
- No PHI collected (unless user voluntarily provides email)
- If email collected, must have BAA with email provider

### Medical Review

**Before Launch**:

- Scoring algorithm reviewed by MD/DO with AATD expertise
- Questions validated against clinical guidelines
- Results language approved by medical advisor
- Legal review of disclaimers

**Ongoing**:

- Annual review of questions and scoring
- Update based on latest clinical guidelines
- Monitor for false positives/negatives (if feedback collected)

---

## 📈 Success Metrics

### Primary KPIs

**Usage**:

- Tool completions per month
- Completion rate (started vs. finished)
- Average time to complete

**Results Distribution**:

- % Low Risk
- % Moderate Risk
- % High Risk
- % Very High Risk

**Actions Taken**:

- % who download doctor guide
- % who find a specialist
- % who email results to self
- % who opt in to follow-up

### Secondary KPIs

**Engagement**:

- Pageviews on tool landing page
- Bounce rate
- Return users (retake assessment)

**Conversion**:

- Newsletter signups from tool
- Forum registrations from tool
- Donations from tool users

### Long-Term Impact

**Diagnosis Tracking** (requires opt-in follow-up):

- "Were you diagnosed with Alpha-1?" survey (3 months post-assessment)
- Track % of high-risk users who got tested
- Track % who received diagnosis

**Goal**: Help 100+ people get diagnosed in Year 1

---

## 💻 Technical Implementation

### Platform Options

**Option 1: Custom WordPress Plugin** (Recommended)

- **Pros**: Integrates seamlessly, full control, one-time cost
- **Cons**: Requires development, maintenance
- **Cost**: $5,000-$8,000
- **Timeline**: 6-8 weeks

**Option 2: Typeform/SurveyMonkey** (Quick Start)

- **Pros**: No code, launch in days, easy to edit
- **Cons**: Less customization, monthly cost, external platform
- **Cost**: $25-$100/month + $1,000 setup
- **Timeline**: 1-2 weeks

**Option 3: React/JavaScript Custom Tool** (Advanced)

- **Pros**: Modern, fast, reusable code
- **Cons**: More expensive, requires ongoing maintenance
- **Cost**: $8,000-$10,000
- **Timeline**: 8-10 weeks

**Recommendation**: Start with **Option 2 (Typeform)** for MVP, then build **Option 1 (Custom Plugin)** once validated.

---

### Technical Requirements

**Frontend**:

- Responsive design (mobile-first)
- Progress bar
- Back/forward navigation
- Answer validation
- Smooth transitions

**Backend**:

- Scoring algorithm (server-side for security)
- Results generation
- Email functionality (if opted in)
- PDF generation (optional)
- Analytics tracking

**Integrations**:

- Google Analytics (track completions, drop-off)
- Mailchimp/email provider (follow-up emails)
- CRM (store leads if opted in)

**Performance**:

- Load time: <1 second per question
- Mobile-optimized
- Works on all browsers (Chrome, Safari, Firefox, Edge)

---

## 🚀 Development Timeline

### Phase 1: Planning (2 weeks)

- [ ] Medical advisor reviews questions and scoring
- [ ] Legal reviews disclaimers
- [ ] Finalize question set (12 questions)
- [ ] Design mockups (Figma)
- [ ] Write all copy (questions, results, resources)

### Phase 2: Development (4-6 weeks)

- [ ] Build quiz interface
- [ ] Implement scoring algorithm
- [ ] Create results pages (4 variations: low, moderate, high, very high)
- [ ] Integrate email functionality
- [ ] Add PDF generation
- [ ] Connect analytics

### Phase 3: Testing (2 weeks)

- [ ] User testing (5-10 people)
- [ ] Medical review of results accuracy
- [ ] Load testing (performance)
- [ ] Mobile testing (iOS, Android)
- [ ] Accessibility testing

### Phase 4: Launch (1 week)

- [ ] Soft launch (to newsletter)
- [ ] Monitor for issues
- [ ] Gather feedback
- [ ] Public launch (social media, website)

**Total Timeline**: 9-11 weeks (2-3 months)

---

## 💰 Budget Breakdown

### Development (One-Time)

| Item                                  | Cost                 |
| ------------------------------------- | -------------------- |
| UI/UX Design (mockups)                | $1,000 - $1,500      |
| Frontend Development (quiz interface) | $2,000 - $3,000      |
| Backend Development (scoring, email)  | $1,000 - $2,000      |
| Content Writing (questions, results)  | $500 - $1,000        |
| Medical Review (MD/DO consultation)   | $500 - $1,000        |
| Legal Review (disclaimers)            | $500 - $1,000        |
| Testing & QA                          | $500 - $1,000        |
| **Total Development**                 | **$6,000 - $10,500** |

### Annual Operating Costs

| Item                       | Cost                          |
| -------------------------- | ----------------------------- |
| Hosting/server (if custom) | $0 (included in site hosting) |
| Email service (follow-ups) | $100 - $300                   |
| Analytics/tracking         | $0 (Google Analytics free)    |
| Annual medical review      | $500                          |
| Updates/maintenance        | $500 - $1,000                 |
| **Total Annual**           | **$1,100 - $1,800**           |

---

## 📊 ROI Analysis

### Direct Revenue (Conservative)

**Year 1 Projections**:

- 1,200 tool completions
- 30% high/very high risk = 360 people
- 20% provide email = 72 leads
- 10% convert to donors = 7 donors @ $50 avg = **$350**

**Not a revenue generator directly**, but...

### Indirect Value

**Traffic & SEO**:

- "Should I get tested for Alpha-1?" ranks high on Google
- Drives 500-1,000 organic visits/month
- Value: $5,000-$10,000/year in advertising equivalent

**Lead Generation**:

- 72 qualified leads (high-risk, opted in)
- Value: $50-$100 per lead = $3,600-$7,200

**Brand Authority**:

- Positions MEF as helpful, innovative, patient-focused
- Differentiates from Alpha-1 Foundation
- PR/media coverage potential

**Lives Changed**:

- If 50 people get diagnosed because of tool: **PRICELESS**
- Early diagnosis = better outcomes = longer lives

**Total Value (Year 1)**: $10,000-$20,000 + immeasurable patient impact

**Payback Period**: 6-12 months

---

## 🎯 Marketing & Promotion

### Launch Strategy

**Pre-Launch (2 weeks before)**:

- Email to newsletter: "Something new is coming..."
- Social media teasers
- Reach out to AATD influencers

**Launch Week**:

- Press release: "New tool helps undiagnosed Alpha-1 patients"
- Email blast: "Should you get tested for Alpha-1?"
- Social media campaign (#GetTested)
- Paid ads (Facebook, Google): Target lung disease keywords

**Post-Launch**:

- Blog posts featuring tool
- Patient testimonials: "This tool led to my diagnosis"
- Partner with Alpha-1 Foundation (cross-promote)
- Medical conference presentations

### SEO Optimization

**Target Keywords**:

- "should I get tested for alpha-1" (low competition)
- "alpha-1 symptoms" (high volume)
- "do I have alpha-1" (medium volume)
- "alpha-1 risk assessment" (low volume)
- "undiagnosed COPD" (indirect)

**On-Page SEO**:

- Title: "Should I Get Tested for Alpha-1? | Free Risk Assessment"
- Meta description: "Take our 3-minute assessment to see if Alpha-1 testing is right for you. 90% of people with Alpha-1 are undiagnosed. Are you one of them?"
- Schema markup (FAQ, Medical Condition)

**Link Building**:

- Partner sites (Alpha-1 Foundation, American Lung Association)
- Medical blogs
- Reddit (r/alpha1, r/COPD)
- Patient forums

---

## 🔄 Future Enhancements (Phase 2)

### Version 2.0 Features

**1. More Detailed Results**

- Break down score by category (lung, liver, family)
- Explain which answers triggered high risk

**2. Symptom Tracker Integration**

- "Track your symptoms over time"
- Compare symptoms before/after diagnosis or treatment

**3. Family Screening Tool**

- "Should my family get tested?" variation
- Focus on family history and genetic risk

**4. Spanish Translation**

- Reach Hispanic/Latino community (higher AATD prevalence in some populations)

**5. Integration with Testing Services**

- Direct booking with genetic counselors
- Partner with AlphaNet or Alpha-1 Foundation for free testing kits

**6. AI-Powered Recommendations**

- More sophisticated risk algorithm using machine learning
- Continuously improve based on outcomes data

---

## ⚠️ Risks & Mitigation

### Risk 1: Medical Accuracy

**Concern**: Giving wrong risk assessment
**Mitigation**:

- Conservative scoring (err on side of recommending testing)
- Strong disclaimers
- Annual medical review
- Track outcomes and adjust algorithm

### Risk 2: Legal Liability

**Concern**: Someone sues because they weren't diagnosed
**Mitigation**:

- Clear disclaimers on every page
- Legal review before launch
- Liability insurance for MEF
- Don't claim to diagnose, only educate

### Risk 3: Low Usage

**Concern**: People don't use the tool
**Mitigation**:

- Heavy marketing at launch
- SEO optimization
- Promote in forums, newsletters, social media
- A/B test landing page to optimize conversion

### Risk 4: False Positives

**Concern**: Too many people score "high risk" who don't have AATD
**Mitigation**:

- Validate scoring with medical advisor
- Track outcomes (survey users post-test)
- Adjust algorithm based on data
- Better to over-recommend testing than under

### Risk 5: Privacy Concerns

**Concern**: Users worried about data sharing
**Mitigation**:

- Clear privacy policy
- Don't store answers unless opted in
- HIPAA-compliant email if collecting addresses
- Option to use tool completely anonymously

---

## ✅ Success Criteria

### Launch Success (Month 1)

- [ ] 100+ tool completions
- [ ] 70%+ completion rate (finished vs. started)
- [ ] 0 critical bugs
- [ ] 4+ minute average time on tool (indicates engagement)

### 6-Month Success

- [ ] 500+ tool completions
- [ ] 50+ email opt-ins (high-risk users)
- [ ] 5+ confirmed diagnoses from tool users (survey)
- [ ] Top 10 Google ranking for "should I get tested for alpha-1"

### 1-Year Success

- [ ] 1,000+ tool completions
- [ ] 100+ email opt-ins
- [ ] 25+ confirmed diagnoses
- [ ] Featured in AATD community as valuable resource
- [ ] Positive feedback from medical community

---

## 🤝 Partnerships & Collaboration

### Potential Partners

**1. Alpha-1 Foundation**

- Cross-promote tool
- Share expertise on question design
- Track outcomes together

**2. AlphaNet**

- Provide free testing kits to high-risk users
- Referrals to disease management program

**3. Genetic Testing Labs**

- Quest Diagnostics, LabCorp
- Educational partnership
- No direct revenue (maintain independence)

**4. Pulmonology Practices**

- Provide tool to their patients
- "Powered by Alpha1Life" white-label version

---

## 📞 Project Team

**Required Roles**:

- **Project Manager**: Overall coordination (20 hours)
- **Medical Advisor**: Question design, scoring review (10 hours)
- **Developer**: Build tool (80-120 hours)
- **Designer**: UI/UX mockups (20 hours)
- **Content Writer**: Questions, results copy (15 hours)
- **Legal Advisor**: Disclaimer review (5 hours)
- **Marketing Manager**: Launch strategy (10 hours)

**Total Estimated Hours**: 160-200 hours

**Timeline**: 9-11 weeks with team in place

---

## 📋 Next Steps

### To Approve This Project:

1. **Budget Approval**: $6,000-$10,500 one-time + $1,100-$1,800/year
2. **Medical Advisor Commitment**: 10 hours over 3 months
3. **Assign Project Manager**: Who will oversee?
4. **Developer Selection**: Hire or contract?
5. **Timeline Approval**: Can we launch in Q1 2026?

### Immediate Actions:

- [ ] Review this document with MEF board
- [ ] Get medical advisor commitment
- [ ] Request proposals from developers
- [ ] Draft initial question set
- [ ] Create project timeline (Gantt chart)

---

**Status**: Ready for approval and implementation

**Recommendation**: **APPROVE** - High impact, low cost, aligns perfectly with MEF mission of helping undiagnosed patients.

---

**End of Symptom Checker Opportunity Document**

**Next Opportunity**: Pharmacy Co-Pay Assistance Automation
